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Respected Editor,
Sudden outbreaks of transpiring viral infections 
are	 putting	 human	 race	 into	 great	 danger.	 Different	
outbreaks	in	the	past	such	as	those	of	Influenza,	Ebola,	
and Zika viruses and the most recent novel coronavirus, 
severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2),	 continue	 to	 remind	 us	 of	 our	 constant	
vulnerability	and	warrant	constant	preparedness	[1].
Emerging	infections	could	be	defined	as	the	ones	whose	
occurrence has increased in the last few years and 
threatens	to	 increase	 in	the	for-coming	years.	Outbreaks	
of disease can be initiated by the transmission of a novel 
pathogen,	or	due	to	reemergence	of	a	known	pathogen	[2].
Viral	 outbreaks	 are	 unpredictable	 because	 they	 result	
from multifaceted interaction between the virus, vector, 
host	and	environment	[3].	Outbreaks	are	likely	to	cause	
fast transmission of disease which might cause high 
morbidity	in	those	affected.	Southeast	Asia	is	at	a	greater	
risk	for	the	outbreak	of	pathogenic	viruses	[2].
Evolutionary changes in pathogens especially viral 
genetic change that allows cross-species transmission 
is the basis of zoonosis which puts humans at risk of 
infecting viruses of animal origin, such was the case 
in	 previous	 outbreaks	 [4].	 This	 is	 aided	 by	 social	 and	
environmental factors - such as increasing global 
population, rapid urbanization, climate change and, 
increased susceptibility to infections due to an aging 
population worldwide - that favor incidence of new viral 
infections	[2].
Quick and precise recognition of emergent pathogens 
is necessary for rapid countermeasures, better clinical 
management, and to reduce the extent of these viral 
infections. For detection, development of diagnostic 




The capability of viruses to cross species barriers, 
acclimatize	 to	 different	 environments,	 and	 to	 resist	
existing vaccines and anti-viral drugs is linked to the 
accretion of mutations in their genome. Hence, genomic 
characterization of new viruses is necessary using DNA 
sequencing strategies that provides critical information 
which helps to develop diagnostic tests, improved drugs, 
and	effective	vaccine	design	[2,	4].	
Vaccination	 has	 proved	 to	 be	 the	 most	 effective	
technique	 to	 eliminate	 pathogenic	 viruses.	 Vaccines	
provide protection by inducing protective immunity and 
their	development	requires	 identification	of	 the	specific	
antigen	that	elicits	an	immune	response	[2].	
The	 current	 outbreak	 of	 SARS-CoV-2	 has	 seen	 rapid	
response	 from	 the	 scientific	 community	 with	 isolation	
and genetic sequencing of the virus completed within 
a short time. The genetic sequence facilitates the 
production of diagnostic PCR tests for the detection 
of	 SARS-CoV-2	 [5].	 Various	 attempts	 at	 developing	 a	
vaccine	against	SARS-CoV-2	are	underway,	with	many	
of the candidates at preclinical stages and few of them 
in	clinical	stages	[6].
To reduce the impact of emerging viral diseases in 
future, establishing local laboratory capacity is critical 
which helps in surveillance, diagnosis, and monitoring 
of emerging diseases. This could be achieved using 
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